(1) and has been confirmed many times since, both in acclimatized natives (2, 3) and in newcomers (4). The relationship of this pulmonary hypertension to the development of high altitude pulmonary edema (HAPE) is uncertain, but pulmonary artery pressure is higher during episodes of HAPE than during control observations in the same individuals (5), and persons who have had such episodes previously have higher pulmonary artery pressures when reexposed to altitude than nonsusceptible individuals under the same conditions (6). Although it is recognized that the peak incidence of HAPE occurs 1-3 days after entry to high altitude (7), it has not been established whether pulmonary arterial pressure rises in a progressive fashion over the same time course. A progressive rise in pulmonary arterial pressure during a 6 wk period at 12,700 ft has been reported in steers, apparently associated with the right heart failure termed "brisket disease" (8), but was not observed in lambs in a matched experiment (9) . Therefore, we decided to investigate in ourselves the time course of the pulmonary arterial pressure both at rest and during exercise at 12,470 ft and to examine other aspects of cardiovascular function over the same time span. We also explored the possibility suggested by Haab, Held, Ernst, and Farhi (10) and Reeves, Halpin, Cohn, and Daoud (11) that hypoxia widens the alveolar to arterial 02 difference.
INTRODUCTION
An increase in pulmonary arterial pressure in man at high altitude was first demonstrated conclusively by Rotta, Canepa, Hurtado, Velasquez, and Chavez in 1956 (1) and has been confirmed many times since, both in acclimatized natives (2, 3) and in newcomers (4) . The relationship of this pulmonary hypertension to the development of high altitude pulmonary edema (HAPE) is uncertain, but pulmonary artery pressure is higher during episodes of HAPE than during control observations in the same individuals (5) , and persons who have had such episodes previously have higher pulmonary artery pressures when reexposed to altitude than nonsusceptible individuals under the same conditions (6) . Although it is recognized that the peak incidence of HAPE occurs 1-3 days after entry to high altitude (7) , it has not been established whether pulmonary arterial pressure rises in a progressive fashion over the same time course. A progressive rise in pulmonary arterial pressure during a 6 wk period at 12,700 ft has been reported in steers, apparently associated with the right heart failure termed "brisket disease" (8) , but was not observed in lambs in a matched experiment (9) . Therefore, we decided to investigate in ourselves the time course of the pulmonary arterial pressure both at rest and during exercise at 12,470 ft and to examine other aspects of cardiovascular function over the same time span. We also explored the possibility suggested by Haab, Held, Ernst, and Farhi (10) 
Subjects
The seven subjects whose physical characteristics are given in Table I were male physicians familiar with the equipment and techniques used in the study. The four subjects participating in the 72 hr acclimatization study were transported to the Barcroft Laboratory (12, 470 ft) in an unpressurized aircraft. Except for a 1 hr stay at 4000 ft, they breathed air enriched with oxygen at flow rates of 2 liters/min while in transit and until catheterization and the control studies had been completed at the Barcroft Laboratory. This flow of oxygen was sufficient to maintain Pao2 over 150 torr. The three subjects who only participated in the summit climb study traveled to altitude by car. They spent 1 night at 10,500 ft and arrived at 12 ,470 ft about 30 hr before the other four subjects.
72 hr acclimatization study Catheterization . Upon arrival at the Barcroft Laboratory, a 36 inch Portex epidural catheter (Portex Ltd., Hythe-Kent, England) with a square cut tip orifice was inserted percutaneously into the left basilic vein and advanced, while monitoring pressure, to the pulmonary artery. A second catheter was placed in the left brachial artery using the Seldinger technique. We intended that these catheters remain in place for 72 hr. Between studies they were filled with heparin and the skin entry sites covered with antibiotic ointment and sterile gauze.
Experiments. Daily complete studies consisted of measurements of pulmonary and systemic arterial pressures, heart rate, cardiac output, arterial and mixed venous blood samples for pH, Po2, Pco2, 02 content, saturation, hemoglobin, osmolarity, oxygen consumption (VO2), static lung compliance (CL), maximum expiratory flow rate (MEFR), functional residual capacity (FRC), and vital capacity (VC). The subjects were studied at rest and during exercise at 60 w with a bicycle ergometer, during 3-5 min at an alveolar Po2 (end tidal) maintained at 40 torr and during 5 min of 100% oxygen breathing. Mixed expired gas was collected to permit calculation of dead space to tidal volume ratio (VD/VT), shunt fractions (Qs/Qt), and alveolar to arterial difference for oxygen (P(A-a)o2). The latter was measured while subjects breathed both ambient air and 100% 02. In addition to these daily studies, we measured pulmonary arterial pressure and arterial and mixed venous blood gas tensions after 6, 12, 30, 36, and 54 hr of hypoxia. All measurements except for lung compliance were made with Blood and expired gas tensions were determined with 02 and C02 electrodes at 370C and the blood values were corrected to body temperature. One oxygen electrode was used for measurements at high Po2, another at low Po2 (i.e., venous blood), to minimize the errors and delays resulting from electrode hysteresis. The high Po2 was also used for analyses of blood 02 content by the method of Klingenmaier, Behar, and Smith (13) , in which Po2 is determined after 50-fold anaerobic dilution of blood with CO-saturated water. Hemoglobin and oxygen saturation were measured with an Instrumentation Laboratories Model 182 CO-Oximeter. Samples were analyzed immediately except for those obtained on the summit which were packed in snow and analyzed 6 hr later at the Barcroft Laboratory. Saturation calculated from Po2 and pH (14) averaged 0.04 42.3% higher than the Instrumentation Laboratories Oximeter reading, while saturation calculated from measured oxygen content and computed capacity (1.34 X Hgb) averaged 2.1 4 3.5% lower than the oximeter readings (P < 0.001).
Frozen serum was transported to San Francisco where osmolarity was determined using a Fiske osmometer (Fiske Associates, Inc., Uxbridge, Mass.).
While breathing air through a Lloyd valve, expired gas was collected for 3 min in a 120 liter Tissot spirometer and its 02 and C02 concentrations determined by electrodes. Oxygen consumption was determined after at least 3 min of preoxygenation using a closed system with CO2 absorber, a Wedge spirometer filled with 100% 02, and a Grass recorder. Methods were altered slightly for the summit climb study in that end tidal samples were collected manually during inspiration from just beyond the expiratory port of the Lloyd nonrebreathing valve and mixed expired gas was collected in a meteorological balloon.
Maximum expiratory flow rate and vital capacity were determined with a wedge spirometer and Grass recorder. FRC was measured by having the subjects rebreathe for 15 sec from a 3.0 liter bag filled with 02 using the technique described by Lundsgaard and Van Slyke (15) , as modified by Severinghaus, Bainton, and Carcelen (16) . Static lung compliance was mea-sured with the subjects seated breathing from a Wedge spirometer. A Statham PM131TC strain gage transduced the differential pressure between mouth pressure and a 10 cm long air-filled esophageal balloon positioned just above the cardia. The balloon was passed via the nose into the stomach (positive deflection with inspiration), withdrawn until a negative deflection on inspiration appeared, and then withdrawn an additional 10 cm. The final balloon volume was adjusted to 0.2 ml. The operator occluded the airway with a solenoid valve for 3 sec at incremental inspired steps of approximately 500 ml until 70-80% of total lung capacity was reached. Similar recordings were then obtained during expiration. Four to six inspiratory and expiratory pressure volume curves were obtained during each compliance determination. Each curve was plotted separately and the values given represent the mean slopes.
Calculations. Alveolar oxygen tension for the determination of P(A-a)o2 and Qs/Qt was calculated from arterial Pco2 and mixed expired gas. When R was not measured it was assumed to be 0.8. Since the measured values for R during the major studies were always greater than 0.8, we probably have underestimated the P(A-a)o2. It was discovered near the end of the study that the O2 demand regulator used for 100% 02 breathing permitted inward leak of enough air to lower Ps02 by 14 torr. PAo0 on 100% 02 was thus (PB-47-Paco2-14). On the summit climb, end tidal Po2 was directly measured. Left atrial pressure was assumed to be zero for the calculation of total pulmonary resistance. The VD/VT calculation includes 46 ml of dead space in the nonrebreathing valve. (17) have observed a shift to the right of the oxygenhemoglobin dissociation curve with chronic hypoxia. They showed Pso (PO2 at 50% saturation, pH 7.4, temperature 370C) rose from the normal value of 27 to about 31 torr. We calculated P50 in mixed venous blood in the four subjects with pulmonary artery catheters, using the directly measured saturation, and Po2, correcting to pH 7.4. No change in P50 with increasing time at altitude was seen in any of the four subjects (Table II) . We therefore used the normal 02 dissociation curve for calculating mixed venous 02 content when neither saturation nor content was directly measured.
Summit climb study
On the fourth day at altitude we investigated the effect of climbing in subject R. H. and three additional subjects who had been at altitude for 5' days (Table I ). P(A-a)o2 and VD/VT were measured while subjects sat at the Barcroft Laboratory (12,470 ft) at 10:00 a.m. They then climbed steadily to the summit laboratory (14,255 ft), a horizontal distance of 5 miles, reaching it at 2:00 p.m. The P(A-a)o2 and VD/VT measurements were repeated on the summit after 1-2 hr rest and agait (except in R. H.) after descent to Barcroft and 2 hr rest. RESULTS 72 hr acclimatization study. The hemodynamic data obtained during the 72 hr study are given in Table III (Fig. 1) . Both resting and exercising heart rates increased during the first 24 hr. The exercising heart rates remained at this higher level while the resting heart rates returned to control levels. Mean brachial arterial blood pressure did not change. Compared to control, resting cardiac output was increased in three of four subjects at 24 hr, and increased in two of three subjects at 48 hr (Fig. 2) Summit climb study. The analytical and gas exchange data for the summit climb study are given in Table IV . The four subjects in this study, one of whom (R. H.) also took part in the 72 hr study, all had normal air and oxygen breathing P(A-a)o2 values before the climb. They were studied in the sitting position. There was an increase in P(A-a)o2 during both air and oxygen breathing after the ascent to the summit with a partial return towards preclimb values after descent. VD/VT did not show this pattern but decreased progressively in three of the four subjects during the course of the day. Preliminary tests of ventilatory response. Before going to altitude, we assessed each subject's ventilatory response to hypoxia both by progressively decreasing alveolar Po2 from 100 to 40 over 3-4 min at a constantly maintained PAcO2, and also with single vital capacity breaths of 5% CO2 in 02, 5% CO2 in N2, 15% CO2 in 02, and 15% CO2 in N2. The latter test was used to assess the contribution of the peripheral chemoreceptors to the ventilatory response to hypoxia without the medullary effects of hypoxia (direct depression, increased blood flow, and thus lowered Pco2) (18) . As shown in Table V, all the subjects had a definite peripheral chemoreceptor response as evidenced by an increase in ventilation on the second and third breaths after a vital capacity inspiration of 15% CO2 in 85% N2. Subject F. W. consistently had the lowest ventilatory response to hypoxia by both the progressive hypoxia and single breath methods, and subject R. H. the highest. Subject F. W. also had the lowest arterial oxygen tensions at altitude and was the only one of the four subjects to develop altitude sickness with headache and vomiting the first night at altitude. He did not exhibit more rise of pulmonary artery pressure than the others.
DISCUSSION
The pulmonary arterial pressure rise seen in this study is similar to that seen by Hultgren, Kelly, and Miller (4) in normal acclimatized adults at 12,300 ft in Peru and by Vogel, Goss, Mori, and Brammell in four subjects 24-48 hr after arrival at 14,260 ft (19) . The increase was due primarily to an increase in total pulmonary resistance (Table II) . These data are consistent with the generally accepted hypothesis that pulmonary hypertension at altitude is due to an increase in pulmonary arteriolar resistance. Pulmonary capillary wedge and left atrial pressure have been found to be normal at altitude (3), even during HAPE (5) .
The rather steady rise of the pulmonary arterial pressure during the first 24 hr of hypoxia is of interest. The level of pulmonary arterial pressure reached after 24 hr was greater in every case than that caused by a 5 min exposure to a PAo2 of 40 torr during the control study, even though the degree of hypoxia during the brief exposure was greater. This finding is consistent with the observation by Grover, Reeves, Will, and Blount (8) in calves that pulmonary artery pressure increases during several weeks at altitude. 5 min of oxygen breathing at various times during the 72 hr study lowered the pulmonary arterial pressure considerably, but in no case was the prehypoxic control pressure achieved. Hultgren, Kelly, and Miller (20) noted that oxygen breathing lowered the pulmonary arterial pressure of acclimatized normal Peruvian natives only about 5 torr. Our study suggests that, as early as 24 hr after altitude exposure, some changes may occur in the pulmonary vascular bed which are not immediately reversible with oxygen.
All the subjects had a similar degree of pulmonary arterial pressure rise (Fig. 5) , but F. W., who had the least ventilatory response to hypoxia, was the only subject with a fall in cardiac output between the control and 24-hr measurements. His total pulmonary resistPulmonary Circulation and Gas Exchange at Altitude ance increased 113% during this period, approximately twice the increase of the other three subjects. We conclude that the ventilatory response to hypoxia may predict the degree of hypoxia and the subsequent effects of that hypoxia on altitude sickness and cardiac output in a subject at altitude, but cannot be used to predict the severity of his pulmonary hypertension. As expected, hypoxia caused an elevation in the resting heart rate in all four subjects. Resting cardiac outputs changed little throughout the study whereas the exercising outputs decreased between 24 and 72 hr at altitude. The time course and direction of the changes in heart rate, stroke volume, and cardiac output are similar to those reported in two young subjects studied at the same altitude by Klausen (21) .
Kreuzer, Tenney, Mithoefer, and Remmers (22) found an increased alveolar to arterial 02 difference (P(A-a)o2) in Andean natives. Haab et al. measured alveolar to arterial differences for N2 and CO2 in nine subjects at 2000 ft and for 5 days after ascent to 11,500 ft (10) . On the basis of calculated predicted values for these variables, they suggested that ventilation/perfusion abnormalities persisted throughout the 5 days of altitude exposure. Reeves et al., by use of more direct measurements, reported an increase in P(A-a)o0 in seven subjects during 4 hr of acute exposure to a simulated altitude of 15,000 ft (11) . Conflicting data has also been reported. Kreuzer et al. (23) reported a decrease in P(A-a)o2 and in shunt fractions in dogs after 5 days exposure to 14,300 ft. Kreuzer and van Lookeren observed no differences in steady-state diffusing capacities for carbon monoxide and oxygen or in P(A-a)o2 in five men studied at seal level and 4560 m (24) . The P(A-a)o2 differences breathing ambient air in our subjects were quantitatively about the same as those observed by Reeves et al. during short exposures to a PB = 425 torr (11) . In addition to the air-breathing gradients, we also observed large-gradients breathing oxygen. These confirm the presence of a significant shunt during the first 72 hr at altitude.
The P(A-a)o2 breathing air remained relatively constant or rose slightly with time while the shunt fractions and the gradients breathing 02 decreased. This would imply a gradual increase in the relative role of ventilation/perfusion (V/Q) abnormalities or diffusion limitation. After 5-7 days at altitude, but before climbing to the summit, the four climbers had normal P(A-a)o1 values, measured while breathing air and oxygen in the sitting position. Climbing to the 14,255 ft summit created abnormally high gradients which returned only part way to normal after descent. Reeves et al. also observed a correlation between increasing exercise and widening P(A-a)o2 in their acute study (11) . In our summit climb study the VD/VT ratio fell progressively even during periods when P(A-a)o2 was rising. This suggests that exercise caused an exacerbation of the J/0 abnormalities seen during the 72 hr study.
None of the subjects developed overt signs of pulmonary edema, although two of the four climbers noted some dyspnea and tachycardia for several hours after the exertion. There was a progressive decrease in the slope of the inspiratory limb of the static pressure volume curve with increasing time at altitude. This is the type of change in lung compliance that has been reported in cases of pulmonary edema; however, our compliances were still 4-5 times greater than those reported for patients in pulmonary edema (26) .
The pathologic source of the widened oxygen gradient cannot be identified. Embolization from the pulmonary artery catheter could have occurred; however, the stability of the pulmonary arterial pressures both on air and 100% 02 after 24 hr are against continued embolization. Another possibility is the presence of subclinical pulmonary edema, both at rest in the catheterized subjects and particularly after exercise in the four climbers. The combined contribution of diffusion limitation and ventilation/perfusion abnormalities to the P(A-a)o2 measured while breathing air, increased during acclimatization. It is not possible to determine whether the increased P(A-a)o2 was due to uneven pulmonary arteriolar constriction, ventilatory maldistribution, or both.
